| IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis SB Coffelt, K Kersten, CW Doornebal, J Weiden, K Vrijland, CS Hau, ... Nature 522 (7556), 345-348, 2015 | 1584 | 2015 |
| Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophages K Kersten, SB Coffelt, M Hoogstraat, NJM Verstegen, K Vrijland, ... Oncoimmunology 6 (8), e1334744, 2017 | 115 | 2017 |
| Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study L Wieske, KPJ van Dam, M Steenhuis, EW Stalman, LYL Kummer, ... The Lancet Rheumatology 4 (5), e338-e350, 2022 | 103 | 2022 |
| Infection History Determines the Differentiation State of Human CD8+ T Cells MC van Aalderen, EBM Remmerswaal, NJM Verstegen, P Hombrink, ... Journal of virology 89 (9), 5110-5123, 2015 | 58 | 2015 |
| Breakthrough SARS-CoV-2 infections with the delta (B. 1.617. 2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy … L Boekel, EW Stalman, L Wieske, F Hooijberg, KPJ van Dam, YR Besten, ... The Lancet Rheumatology 4 (6), e417-e429, 2022 | 49 | 2022 |
| Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases L Wieske, LYL Kummer, KPJ van Dam, EW Stalman, AJ van der Kooi, ... BMC medicine 20 (1), 100, 2022 | 23 | 2022 |
| Longitudinal T-cell responses after a third SARS-CoV-2 vaccination in patients with multiple sclerosis on ocrelizumab or fingolimod V Palomares Cabeza, LYL Kummer, L Wieske, RR Hagen, M Duurland, ... Neurology: Neuroimmunology & Neuroinflammation 9 (4), e1178, 2022 | 22 | 2022 |
| Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: to wait and repopulate? ZLE van Kempen, L Wieske, EW Stalman, LYL Kummer, PJ van Dam, ... Multiple sclerosis and related disorders 57, 103416, 2022 | 22 | 2022 |
| Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273 NJM Verstegen, RR Hagen, J van den Dijssel, LH Kuijper, C Kreher, ... Elife 11, e77969, 2022 | 18 | 2022 |
| System-level scenarios for the elucidation of T cell-mediated germinal center B cell differentiation NJM Verstegen, V Ubels, HV Westerhoff, SM Van Ham, M Barberis Frontiers in immunology 12, 734282, 2021 | 13 | 2021 |
| Breakthrough infections with the SARS-CoV-2 omicron (B. 1.1. 529) variant in patients with immune-mediated inflammatory diseases EW Stalman, L Wieske, KPJ van Dam, LY Kummer, ZLE van Kempen, ... Annals of the rheumatic diseases 81 (12), 1757-1766, 2022 | 12 | 2022 |
| Parallel detection of SARS‐CoV‐2 epitopes reveals dynamic immunodominance profiles of CD8+ T memory cells in convalescent COVID‐19 donors J van den Dijssel, RR Hagen, R de Jongh, M Steenhuis, T Rispens, ... Clinical & translational immunology 11 (10), e1423, 2022 | 12 | 2022 |
| Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations KPJ van Dam, L Wieske, EW Stalman, LYL Kummer, J Roosen, ... Journal of autoimmunity 135, 102984, 2023 | 11 | 2023 |
| Minimalistic in vitro culture to drive human naive B cell differentiation into antibody-secreting cells PPA Unger, NJM Verstegen, C Marsman, T Jorritsma, T Rispens, ... Cells 10 (5), 1183, 2021 | 11 | 2021 |
| Termination of CD40L co‐stimulation promotes human B cell differentiation into antibody‐secreting cells C Marsman, NJM Verstegen, M Streutker, T Jorritsma, L Boon, ... European journal of immunology 52 (10), 1662-1675, 2022 | 9 | 2022 |
| Single-cell analysis reveals dynamics of human B cell differentiation and identifies novel B and antibody-secreting cell intermediates NJM Verstegen, S Pollastro, PPA Unger, C Marsman, G Elias, T Jorritsma, ... Elife 12, e83578, 2023 | 6 | 2023 |
| Human B cells engage the NCK/PI3K/RAC1 axis to internalize large particles via the IgM-BCR NJM Verstegen, PPA Unger, JZ Walker, BP Nicolet, T Jorritsma, ... Frontiers in immunology 10, 415, 2019 | 6 | 2019 |
| Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity KPJ Van Dam, AG Volkers, L Wieske, EW Stalman, LYL Kummer, ... BMC Infectious Diseases 23 (1), 332, 2023 | 2 | 2023 |
| Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases L Wieske, EW Stalman, PJK van Dam, LY Kummer, M Steenhuis, ... Annals of the rheumatic diseases 82 (6), 883-885, 2023 | 1 | 2023 |
| DOP27 Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy-a Target to B! study A Volkers, L Wieske, K van Dam, M Steenhuis, E Stalman, L Kummer, ... Journal of Crohn's and Colitis 16 (Supplement_1), i079-i079, 2022 | 1 | 2022 |
